Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Chronic | Lymphocytic | Leukemia | B-Cell
Age: Between 18 - 100 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required